A. Doust

发表

Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1)

J. Norrie, L. Hummelshoj, P. Chien, 2021, Pilot and Feasibility Studies.

Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC)

Y. Bagger, P. Saunders, L. Williams, 2021, Pilot and Feasibility Studies.

Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol

J. Norman, J. Mollison, W. C. Duncan, 2013, BMJ Open.

GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol

S. Lewis, H. Critchley, A. Horne, 2012, BMJ Open.

Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial☆

J. Mollison, T. Johns, A. Horne, 2018, EBioMedicine.

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

I. Tracey, M. Feltham, R. Cregg, 2020, The Lancet.

Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial

T. Bourne, C. Bottomley, U. Menon, 2023, The Lancet.

Correction: A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1)

P. Saunders, L. Williams, F. Denison, 2020, PloS one.

A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol

C. Bottomley, B. Mol, A. Coomarasamy, 2018, Trials.

A multi-centre , double-blind , placebo-controlled , randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies ( GEM 3 )

C. Bottomley, B. Mol, A. Coomarasamy, 2018 .

A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1)

P. Saunders, L. Williams, F. Denison, 2020, PloS one.

A pilot randomised double blind controlled trial of the efficacy of purified fatty acids for the treatment of women with endometriosis-associated pain (PurFECT): study protocol

P. Saunders, L. Williams, F. Denison, 2018, Pilot and Feasibility Studies.

Effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women (ESPriT2): protocol for a multi-centre randomised controlled trial

J. Norrie, L. Hummelshoj, Y. Cheong, 2023, Trials.

Early (Days 1–4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy

A. Horne, W. Duncan, S. Tong, 2023, Human reproduction.

University of Birmingham A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3)

T. Bourne, C. Bottomley, A. Coomarasamy, 2018 .

Gabapentin to reduce pain in women aged between 18 and 50 years with chronic pelvic pain: the GaPP2 RCT

H. Whalley, L. Romaniuk, L. Middleton, 2020, Efficacy and Mechanism Evaluation.

Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial

E. Denny, U. Poultney, K. Tryposkiadis, 2024, BMJ.